430 related articles for article (PubMed ID: 12801594)
1. Substance P and cholecystokinin regulate neurochemical responses to cocaine and methamphetamine in the striatum.
Loonam TM; Noailles PA; Yu J; Zhu JP; Angulo JA
Life Sci; 2003 Jun; 73(6):727-39. PubMed ID: 12801594
[TBL] [Abstract][Full Text] [Related]
2. Antagonists of the neurokinin-1 or dopamine D1 receptors confer protection from methamphetamine on dopamine terminals of the mouse striatum.
Angulo JA; Angulo N; Yu J
Ann N Y Acad Sci; 2004 Oct; 1025():171-80. PubMed ID: 15542715
[TBL] [Abstract][Full Text] [Related]
3. Neurokinin-1 (NK-1) receptor antagonists abrogate methamphetamine-induced striatal dopaminergic neurotoxicity in the murine brain.
Yu J; Cadet JL; Angulo JA
J Neurochem; 2002 Nov; 83(3):613-22. PubMed ID: 12390523
[TBL] [Abstract][Full Text] [Related]
4. Ontogeny of neurokinin-1 receptor mediation of methamphetamine neurotoxicity in the striatum of the mouse brain.
Yu J; Allison S; Ibrahim D; Cadet JL; Angulo JA
Ann N Y Acad Sci; 2002 Jun; 965():247-53. PubMed ID: 12105100
[TBL] [Abstract][Full Text] [Related]
5. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
[TBL] [Abstract][Full Text] [Related]
6. Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey.
Melega WP; Lacan G; Desalles AA; Phelps ME
Synapse; 2000 Mar; 35(4):243-9. PubMed ID: 10657033
[TBL] [Abstract][Full Text] [Related]
7. Neurokinin receptors modulate the neurochemical actions of cocaine.
Noailles PA; Angulo JA
Ann N Y Acad Sci; 2002 Jun; 965():267-73. PubMed ID: 12105102
[TBL] [Abstract][Full Text] [Related]
8. Distinct mechanisms mediating methamphetamine-induced neuronal apoptosis and dopamine terminal damage share the neuropeptide substance p in the striatum of mice.
Zhu JP; Xu W; Angulo JA
Ann N Y Acad Sci; 2006 Aug; 1074():135-48. PubMed ID: 17105911
[TBL] [Abstract][Full Text] [Related]
9. Histological evidence supporting a role for the striatal neurokinin-1 receptor in methamphetamine-induced neurotoxicity in the mouse brain.
Yu J; Wang J; Cadet JL; Angulo JA
Brain Res; 2004 May; 1007(1-2):124-31. PubMed ID: 15064143
[TBL] [Abstract][Full Text] [Related]
10. Substance P modulates cocaine-evoked dopamine overflow in the striatum of the rat brain.
Kraft M; Noailles P; Angulo JA
Ann N Y Acad Sci; 2001 Jun; 937():121-31. PubMed ID: 11458533
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions.
Zhang Y; Loonam TM; Noailles PA; Angulo JA
Ann N Y Acad Sci; 2001 Jun; 937():93-120. PubMed ID: 11458542
[TBL] [Abstract][Full Text] [Related]
12. Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence.
Baumann MH; Phillips JM; Ayestas MA; Ali SF; Rice KC; Rothman RB
Ann N Y Acad Sci; 2002 Jun; 965():92-108. PubMed ID: 12105088
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin facilitates methamphetamine-induced dopamine overflow in rat striatum and fetal ventral mesencephalic grafts.
Wang Y; Perng SL; Lin JC; Tsao WL
Exp Neurol; 1994 Dec; 130(2):279-87. PubMed ID: 7867757
[TBL] [Abstract][Full Text] [Related]
14. Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine.
Cass WA
J Pharmacol Exp Ther; 1997 Jan; 280(1):105-13. PubMed ID: 8996187
[TBL] [Abstract][Full Text] [Related]
15. Modulation of acetylcholine release by cholecystokinin in striatum: receptor specificity; role of dopaminergic neuronal activity.
Petkova-Kirova P; Giovannini MG; Kalfin R; Rakovska A
Brain Res Bull; 2012 Dec; 89(5-6):177-84. PubMed ID: 22981453
[TBL] [Abstract][Full Text] [Related]
16. Prenatal cocaine exposure alters potassium-evoked dopamine release dynamics in rat striatum.
Salvatore MF; Hudspeth O; Arnold LE; Wilson PE; Stanford JA; MacTutus CF; Booze RM; Gerhardt GA
Neuroscience; 2004; 123(2):481-90. PubMed ID: 14698755
[TBL] [Abstract][Full Text] [Related]
17. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
Bjorklund NL; Sorg BA; Schenk JO
Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
[TBL] [Abstract][Full Text] [Related]
18. Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice.
Zhu JP; Xu W; Angulo JA
Brain Res; 2005 Jul; 1049(2):171-81. PubMed ID: 16043139
[TBL] [Abstract][Full Text] [Related]
19. Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors.
Xu W; Zhu JP; Angulo JA
Synapse; 2005 Nov; 58(2):110-21. PubMed ID: 16088948
[TBL] [Abstract][Full Text] [Related]
20. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
Hansen JP; Riddle EL; Sandoval V; Brown JM; Gibb JW; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2002 Mar; 300(3):1093-100. PubMed ID: 11861820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
